Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
10 studies found for:    "gene therapy" OR "gene transfer" OR "virus delivery" | Cystic Fibrosis
Show Display Options
Rank Status Study
1 Completed Repeated Application of Gene Therapy in CF Patients
Condition: Cystic Fibrosis
Interventions: Drug: pGM169/GL67A;   Drug: Placebo
2 Completed Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
Condition: Cystic Fibrosis
Intervention: Genetic: pGT-1 gene lipid complex
3 Completed Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Genetic: Cystic fibrosis transmembrane conductance regulator
4 Unknown  Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Adeno-associated virus-CFTR vector
5 Terminated Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Genetic: tgAAVCF
6 Completed Single Dose of pGM169/GL67A in CF Patients
Condition: Cystic Fibrosis
Intervention: Drug: pGM169/GL67A
7 Completed Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Genetic: H5.001CBCFTR
8 Completed Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Genetic: Ad5-CB-CFTR
9 Unknown  Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis
Condition: Bronchopulmonary Infection
Intervention: Other: sputum samples
10 Completed
Has Results
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
Condition: Cystic Fibrosis
Interventions: Drug: Ivacaftor;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.